Amicus Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Amicus Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Amicus Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Amicus Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company, which discovers, develops, and commercializes small molecule drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's strong market position in rare diseases, research and development pipeline, and improvement in Galafold's revenue are its strengths even as dependence on external manufacturing could be a major cause for concern to the company. Amicus Therapeutics could benefit from the market potential of Fabry disease in the US, expansion through strategic alliances, capitalizing on regulatory milestones and promising clinical trials. However, its performance could be affected by the competitive environment, uncertainties in R&D, and stringent government regulations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer